Delivery Order SPE2DB20D1050-SPE2DB25FH92M
Award Date 9/19/25
Potential Completion Date 9/22/25
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $2,936.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Pulmozyme 1 mg/ml ampules (2.5 ml units). This non-competitive, competitively awarded delivery order is scheduled for completion by September 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Pulmozyme is a prescription medication used to treat cystic fibrosis by reducing mucus...
- The Defense Logistics Agency awarded a delivery order valued at $30,166.02 to AmerisourceBergen Drug Corp for the supply of Pulmozyme 1 mg/ml ampules (2.5 ml) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Pulmozyme is a prescribed medication used primarily in the treatment of cystic fibrosis,...
- The Defense Logistics Agency awarded a delivery order valued at $2,594.39 to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/ml ampules (2.5 ml) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract requires performance at AmerisourceBergen's Conshohocken, Pennsylvania location. Pulmozyme is a recombinant human deoxyribonuclease used primarily in the treatment of cystic fibrosis, reflecting the Defense Logistics Agency's ongoing...
- The Defense Logistics Agency awarded a $4,516.47 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Pulmozyme 1 mg/ml ampules (2.5 ml). This is a non-set-aside contract with an ultimate completion date of September 19, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $34,013.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Pulmozyme 1 mg/ml ampul 2.5ml, a medication used to treat cystic fibrosis. This is a non-set-aside competitive award with an ultimate completion date of July 15, 2025, and performance to be conducted at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $45,918.14 to AmerisourceBergen Drug Corp for the supply of Pulmozyme 1 mg/mL ampules (2.5 mL units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 29, 2025, with performance to be executed at the awardee's facility in Conshohocken, Pennsylvania. The contract contains no small business set-aside designation, reflecting the competitive nature of the procurement. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $13,882.26 to AmerisourceBergen Drug Corp for the supply of Pulmozyme 1 mg/mL ampules (2.5 mL) on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a discrete delivery of this specialty...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,152.50 to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Pulmozyme 1 mg/ml ampule 2.5ml. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion on September 17, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Pulmozyme 1 mg/mL ampules (2.5 mL) at a ceiling value of $6,286.98. This firm fixed-price delivery order, with an ultimate completion date of July 24, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor. The performance location is...
- The Defense Logistics Agency awarded a $11,346.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Pulmozyme 1 mg/ml ampuls in 2.5 ml units. The contract, with an ultimate completion date of September 15, 2025, carries no set-aside designation and represents a competitive award under AmerisourceBergen's existing federal pharmaceutical supply agreements. Performance will be executed from the contractor's Corporate Office location in...